美国接受丁丙诺啡豁免的医生每月接诊患者人数。
Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US.
机构信息
Substance Use Prevention and Treatment Initiative, The Pew Charitable Trusts, Washington, DC.
Deerfield Institute, Deerfield Management Company, New York, New York.
出版信息
JAMA Netw Open. 2020 Aug 3;3(8):e2014045. doi: 10.1001/jamanetworkopen.2020.14045.
Abstract
This cross-sectional study examines the number of patients prescribed buprenorphine by US clinicians who were waivered to treat 30, 100, or 275 patients concurrently.
摘要
本横断面研究考察了获得同时治疗 30、100 或 275 名患者豁免权的美国临床医生开出丁丙诺啡处方的患者人数。
相似文献
1
Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US.美国接受丁丙诺啡豁免的医生每月接诊患者人数。
JAMA Netw Open. 2020 Aug 3;3(8):e2014045. doi: 10.1001/jamanetworkopen.2020.14045.
2
Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.2007 - 2017年美国丁丙诺啡豁免处方医生的增长与分布情况
Ann Intern Med. 2020 Apr 7;172(7):504-506. doi: 10.7326/M19-2403. Epub 2020 Jan 7.
3
Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.农村医生开具丁丙诺啡处方的规定豁免。
Am J Prev Med. 2018 Jun;54(6 Suppl 3):S208-S214. doi: 10.1016/j.amepre.2018.02.006.
4
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.美沙酮处方医师人数与医疗补助计划参保者美沙酮治疗使用和处方类阿片药物使用的关联。
JAMA Netw Open. 2018 Sep 7;1(5):e182943. doi: 10.1001/jamanetworkopen.2018.2943.
5
Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.美国美沙酮处方医生对患者的关注程度。
JAMA. 2021 Jun 1;325(21):2206-2208. doi: 10.1001/jama.2021.4469.
6
Family Physicians Play Key Role in Bridging the Gap in Access to Opioid Use Disorder Treatment.家庭医生在弥合阿片类物质使用障碍治疗可及性差距方面发挥关键作用。
Am Fam Physician. 2020 Jul 1;102(1):10.
7
Prescribing patterns of buprenorphine waivered physicians.有资格开丁丙诺啡的医师的处方模式。
Drug Alcohol Depend. 2017 Dec 1;181:213-218. doi: 10.1016/j.drugalcdep.2017.10.002. Epub 2017 Oct 18.
8
Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.数据点：接受阿片类激动剂治疗患者苯二氮䓬类药物处方的地区差异
Psychiatr Serv. 2014 Jan 1;65(1):4. doi: 10.1176/appi.ps.650308.
9
Why aren't physicians prescribing more buprenorphine?为什么医生没有开出更多的丁丙诺啡？
J Subst Abuse Treat. 2017 Jul;78:1-7. doi: 10.1016/j.jsat.2017.04.005. Epub 2017 Apr 12.
10
Physicians' satisfaction with providing buprenorphine treatment.医生对提供丁丙诺啡治疗的满意度。
Addict Sci Clin Pract. 2019 Aug 26;14(1):34. doi: 10.1186/s13722-019-0163-3.
引用本文的文献
1
Perceived organizational support for the treatment of opioid use disorder and its association with primary care provider treatment willingness and medication prescribing.对阿片类物质使用障碍治疗的组织支持感知及其与初级保健提供者治疗意愿和药物处方的关联。
J Subst Use Addict Treat. 2025 Apr;171:209623. doi: 10.1016/j.josat.2025.209623. Epub 2025 Jan 24.
2
The Implementation Climate for Integrating Buprenorphine Prescribing into Rural Primary Care.将丁丙诺啡处方纳入农村初级保健的实施环境
J Gen Intern Med. 2024 Dec 12. doi: 10.1007/s11606-024-09260-1.
3
Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements.放松 X 豁免培训要求后丁丙诺啡的处方特征。
JAMA Netw Open. 2024 Aug 1;7(8):e2425999. doi: 10.1001/jamanetworkopen.2024.25999.
4
Initiation of Buprenorphine in the Emergency Department: A Survey of Emergency Clinicians.在急诊科开始使用丁丙诺啡：对急诊临床医生的调查。
West J Emerg Med. 2024 Jul;25(4):470-476. doi: 10.5811/westjem.18029.
5
The potential impact of clinical decision support on nonwaivered primary care clinicians' prescribing of buprenorphine.临床决策支持对未放弃开具丁丙诺啡处方的基层医疗临床医生的潜在影响。
Health Aff Sch. 2023 Oct 11;1(4):qxad051. doi: 10.1093/haschl/qxad051. eCollection 2023 Oct.
6
Understanding and Addressing Widening Racial Inequalities in Drug Overdose.理解并解决药物过量导致的日益严重的种族不平等问题。
Am J Psychiatry. 2024 May 1;181(5):381-390. doi: 10.1176/appi.ajp.20230917.
7
Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018.阿片类物质使用障碍治疗中大量开处丁丙诺啡处方医生的重要性日益增加：2009-2018 年。
Drug Alcohol Depend. 2024 Jun 1;259:111290. doi: 10.1016/j.drugalcdep.2024.111290. Epub 2024 Apr 16.
8
Primary care professionals' perspectives on tailoring buprenorphine training for rural practice.基层医疗保健专业人员对调整丁丙诺啡培训以适应农村实践的看法。
J Rural Health. 2024 Sep;40(4):671-680. doi: 10.1111/jrh.12832. Epub 2024 Mar 14.
9
Rural-urban disparities in the availability of hospital-based screening, medications for opioid use disorder, and addiction consult services.城乡之间在医院提供的筛查、阿片类药物使用障碍和成瘾咨询服务方面存在差异。
J Subst Use Addict Treat. 2024 May;160:209280. doi: 10.1016/j.josat.2023.209280. Epub 2023 Dec 22.
10
Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.美国有和没有 X 豁免培训的初级保健专业人员在丁丙诺啡处方准备方面的差异。
Harm Reduct J. 2023 Dec 21;20(1):180. doi: 10.1186/s12954-023-00918-3.
本文引用的文献
1
Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.克服开具丁丙诺啡用于治疗阿片类药物使用障碍的障碍：农村医生的建议。
J Rural Health. 2019 Jan;35(1):113-121. doi: 10.1111/jrh.12328. Epub 2018 Oct 19.
2
Prescribing patterns of buprenorphine waivered physicians.有资格开丁丙诺啡的医师的处方模式。
Drug Alcohol Depend. 2017 Dec 1;181:213-218. doi: 10.1016/j.drugalcdep.2017.10.002. Epub 2017 Oct 18.
3
Why aren't physicians prescribing more buprenorphine?为什么医生没有开出更多的丁丙诺啡？
J Subst Abuse Treat. 2017 Jul;78:1-7. doi: 10.1016/j.jsat.2017.04.005. Epub 2017 Apr 12.
4
Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment.医生使用丁丙诺啡辅助治疗阿片类物质使用障碍的能力。
JAMA. 2016 Sep 20;316(11):1211-1212. doi: 10.1001/jama.2016.10542.
Zotero 插件